Another retraction of Spirocor research

Remember Spirocor, the Israeli company that closed down a clinical trial involving its “respiratory stress” test for coronary artery disease because the data underpinning the validity of the method proved unreliable? The problem led to the retraction of two articles, about which we’ve previously reported. But we also found a study by some of the same researchers, who include scientists in Israel and the United States, that had been presented at the 2010 meeting of the American Heart Association and published in the journal Circulation.

That abstract, No. 14426 “Accuracy and Usefulness of Finger Pulse Wave Analysis during Brief Deep Breathing Exercise (Respiratory Stress Response) as a Marker of Significant Coronary Artery Disease,” has now been retracted — making, to our knowledge, the entire body of published research on the Spirocor product an editorial memory.

Here’s the notice, which appears within the text of the abstract: Continue reading Another retraction of Spirocor research

Sigh: “The purpose of keeping these retraction notices slim is not to produce too much detail”

Regular readers of this blog by now know that one of our goals is to make retractions as open and informative as possible. Which is why when they’re not, we get irritated that not everyone seems to agree.

Consider the editors of Computational and Theoretical Chemistry, which this month has retracted two papers from a group of researchers in Iran. The articles were titled “Determination of the electrode potentials for substituted 1,2-dihydroxybenzenes in aqueous solution: Theory and experiment” first published online in July 2006 and cited 25 times, according to the Thomson Scientific Web of Knowledge, and “Calculation of electrode potentials of 5-(1,3-dioxo-2-phenyl-indan-2-yl)-2,3-dihydroxy-benzoic acid, molecular structure and vibrational spectra: A combined experimental and computational study,” which appeared in December 2006. (Both articles were published in the journal’s previous incarnation as the Journal of  Molecular Structure: THEOCHEM.)

The reason given in each case  is the same — and tantalizingly cryptic: Continue reading Sigh: “The purpose of keeping these retraction notices slim is not to produce too much detail”

More on Applied Mathematics Letters: Journal retracted paper questioning second law of thermodynamics

Have you read yesterday’s post on a retraction in Applied Mathematics Letters yet? (If you haven’t, you’ve missed the explanation of how “Both science and spirituality came from space,” along with other oddities. We’ll wait while you go read it.) But for those of you who have, it turns out that this wasn’t the first retraction of a bizarre paper in the journal this year.

In January, Granville Sewell, of the University of Texas, El Paso’s math department, published a paper there called “A Second Look at The Second Law.” Its abstract: Continue reading More on Applied Mathematics Letters: Journal retracted paper questioning second law of thermodynamics

Faked data, unsubstantiated claims, and spirituality add up to a math journal retraction

Sometimes, things just don’t add up. Take this retraction notice, from the March 2011 issue of Applied Mathematics Letters:

This article has been retracted at the request of the editor as the authors have falsified mathematical findings and have made unsubstantiated claims regarding Euclid’s parallel postulate (Appl. Math. Lett. 23 (2010) 1137–1139. doi:10.1016/j.aml.2010.05.003). This article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.

There’s actually only one author, an M. Sivasubramanian, of Dr. Mahalingam College of Engineering and Technology, Pollachi, Tamil Nadu, India, but we’re not PhDs in math, so we figured we were missing something important. Fortunately, Ben Steinberg, a high school friend of one of ours — Ivan’s — is a bit of a math rock star and a professor at Carleton University. We asked him for his take:

I am not sure which is more amusing, the article or the retraction. I cannot understand how this could possibly be published anywhere. It seems like a practical joke to test whether articles are actually refereed. Not a single statement in the author’s “proof” makes sense. Continue reading Faked data, unsubstantiated claims, and spirituality add up to a math journal retraction

Aftermath: Gut-wrenching misstep leads to retraction, frayed feelings and a paperless postdoc

Graham Ellis-Davies says January 25th was one of the worst days of his life. That was when the journal ChemBioChem retracted an article, published barely two weeks earlier, for a mistake Ellis-Davies blames squarely on himself.

The fallout has been nearly two months of painful self-recrimination, a tattered friendship and, perhaps most significant, he adds, the wasted effort of a postdoc who poured months of research into a now worthless publication. Continue reading Aftermath: Gut-wrenching misstep leads to retraction, frayed feelings and a paperless postdoc

Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

The tenth of 12 promised retractions by Silvia Bulfone-Paus and colleagues has appeared, in the Journal of Biological Chemistry (JBC).

The paper, “Reverse signaling through membrane-bound Interleukin-15,” was published in 2004 and has been cited 31 times, according to Thomson Scientific’s Web of Knowledge. The retraction notice, just like the other one for the team’s work that appeared in the JBC, was completely uninformative: Continue reading Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

As the news of Joachim Boldt’s staggering number of retractions leaps from Retraction Watch into the mainstream press, the consortium of journal editors retracting his studies has backtracked ever so slightly, announcing today that one of the 89 studies for which the German anesthesiologist lacked ethics approval in fact had such sanction.

According to the now-16 (Updated 3/7/11, as it is up from 11 several days ago) editors, LÄK-RLP,  the German body investigating the ethics component of the Boldt case: Continue reading Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

Plagiarism and other ‘negligence’ fell lung-estrogen paper

There’s parsing a-plenty in the American Journal of Physiology Lung Cellular and Molecular Physiology this month. The journal has retracted a 2010 paper by researchers at Chiba University in Japan, who lifted much of their manuscript from an article by other scientists in a different publication.

The authors of the paper, “The estrogen paradox in pulmonary arterial hypertension,” confess that they misappropriated text. But how they do so is a case study in subtlety: Continue reading Plagiarism and other ‘negligence’ fell lung-estrogen paper

Two more retractions for Mori make 16 — but not a record

Biochemical Journal has retracted two articles by Naoki Mori, bringing the total number of pulled papers by the Japanese cancer researcher to sixteen.

As with the previous Mori retractions, the latest ones — of papers published in 2007 and 2010 — involve unreliable images. Mori, you’ll recall, had recycled control blots from study to study over the years, and was dismissed from his academic post in August.

The 2007 paper, “Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells,” also included a frequent co-author Mariko Tomita, who has been implicated in the deception. It has been cited 15 times, according to Thomson Scientific’s Web of Knowledge. The 2010 article, “Inhibition of Akt/GSK3β signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis,” has not yet been cited.

In each case, the retraction notice is the same: Continue reading Two more retractions for Mori make 16 — but not a record

22 papers by Joachim Boldt retracted, and 67 likely on the way

Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.

Anesthesia & Analgesia has retracted 22 papers by Joachim Boldt, the discredited German anesthesiologist whose prolific career as a researcher has unraveled with stunning rapidity — and 67 more retractions are likely on the way from 10 other titles  that have published his work.

The 22 retractions, announced Feb. 25 on the journal’s website, come less than a month after the state medical board overseeing an investigation into Boldt’s publications said that it was looking into more than 90 of his articles out of concern that he had failed to obtain proper approval from an institutional review board for the work.

The board, Landesärztekammer Rheinland-Pfalz (LÄK-RLP), investigated 102 articles. Investigators could not find evidence of adequate IRB approval for 89 papers; for the remaining, 11 had IRB approval and two did not require it, according to the A&A notice, which was signed by  editor-in-chief Steven L. Shafer: Continue reading 22 papers by Joachim Boldt retracted, and 67 likely on the way